The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The Japan dry eye syndrome market size reached US$ 128.2 Million in 2021. Looking forward IMARC Group expects the market value to reach US$ 166.65 Million by 2027, growing at a CAGR of 4.30% during the forecast period (2022-2027). Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Dry eye syndrome, or keratoconjunctivitis sicca (KCS), is a medical disorder that occurs due to the lack of adequate moisture or lubrication on the surface of the eyes. It is a chronic ailment characterized by redness, itching, aching, discomfort, pain, burning sensation in the eyes and photophobia. It can be caused due to extensive computer usage, menopause, allergies, deficiency of vitamin A, laser surgeries and autoimmune diseases. The syndrome can be treated by administering artificial tears, lacrimal plugs, medications and various surgical procedures. It can also be prevented by wearing wraparound sunglasses or other protective eyewear.
The growth in the Japan dry eye syndrome market can be attributed to the rising geriatric population. Dry eye syndrome is also widely associated with various medical conditions, such as diabetes, Sjogren's syndrome, arthritis, thyroid disorders, lupus and scleroderma that is highly prevalent among the elderly population. In addition to this, the increasing inclination toward activities requiring excessive screen time is also impacting the occurrence of the syndrome. These activities cause a high strain on the eyes, leading to fatigue and lack of lubrication. Moreover, various product innovations, such as the development of functional visual acuity meter devices that can measure changes in continuous visual acuity over time, are providing a thrust to the market growth. In line with this, the widespread adoption of hyaluronic acid that assists in retaining moisture and effectively treating dry eye syndrome is positively impacting the market growth. Other factors, including significant improvements in diagnostic technologies, along with rising healthcare expenditure capacities of the masses, are creating a positive outlook for the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the Japan dry eye syndrome market, along with forecasts at the country and regional level from 2022-2027. Our report has categorized the market based on disease type, drug type, product and distribution channel.
Breakup by Disease Type:
Breakup by Drug Type:
Breakup by Product:
Breakup by Distribution Channel:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
|Base Year of the Analysis||2021|
|Segment Coverage||Disease Type, Drug Type, Product, Distribution Channel, Region|
|Region Covered||Kanto Region, Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, Shikoku Region|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
Infantile Spasms Therapeutics Market by Therapeutic Class (Anticonvulsants, Corticosteroids, and Others), Drug Type (Vigabatrin, Adrenocorticotropic Hormone, and Others (Phase III)), Dosage (Solid, Liquid), Route of Administration (Oral, Parenteral, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), End User (Hospitals, Clinics, and Others), and Region 2023-2028
Hyperphosphatemia Drugs Market by Product (Sevelamer, Calcium Based Phosphate Binders, Iron Based Phosphate Binders, Lanthanum Carbonate, and Others), Dosage Form (Tablets, Syrups, Capsules), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2023-2028
Urology Robotic Surgery Market by Component (Robotic Surgery Systems, Instruments and Accessories, Services), Application (Robotic Prostatectomy, Robotic Cystectomy, Robotic Pyeloplasty, Robotic Nephrectomy, and Others), and Region 2023-2028
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at